News
What is the flow cytometry market?Flow cytometry is a technique employed in laboratories to analyze the physical and chemical ...
The transaction, approved by both companies' boards of directors, is expected to close by the end of the first quarter of ...
SAN ANTONIO, July 15, 2025--bioAffinity Technologies has received notification of allowance from China for a patent on its ...
2h
Zacks Investment Research on MSNBD Partners With Waters to Build High-Volume Diagnostics LeaderBecton, Dickinson and Company BDX, popularly known as BD, and Waters Corporation WAT recently announced a strategic collaboration to combine BD’s Biosciences Diagnostic Solutions business with Waters’ ...
BD has found a new home for its biosciences and diagnostics divisions at the lab equipment maker Waters Corporation, through ...
Waters Corp.'s $17.5B merger with BD Biosciences aims to double revenue but raises risks. Read here for an investment ...
Waters plans to combine with the Biosciences & Diagnostic Solutions business of BD (Becton, Dickinson & Co.), the companies said, in a $17.5 billion deal that would be the year’s largest within life ...
Key Takeaways Waters said it reached a deal to buy the Biosciences & Diagnostic Solutions business of Becton Dickinson for ...
BD (NYSE: BDX) and Waters announced an agreement to create a new life science and diagnostics leader through a business ...
Kirkland & Ellis advises Waters on $17.5B merger with Becton Dickinson, creating a diagnostics and life sciences leader.
Becton, Dickinson and Company is an attractive firm that just made a good deal. Click here to find out why BDX stock is a Buy ...
The global sepsis diagnostics market size was US$ 570 million in 2021. The global sepsis diagnostics market size is forecast to reach US$ 1,111.26 million by 2030, growing at a compound annual growth ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results